Use of low dose IL-2 for treating autoimmune—related or inflammatory disorders
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Assistance Publique-Hopitaux de Paris, Sorbonne Universite
InventorsDavid Klatzmann, David Saadoun, Patrice Cacoub, Michèle Rosenzwajg, Eliane Piaggio, Gilbert Bensimon, Claude Bernard
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
Claims10
A method for treating systemic vasculitis, the method comprises administering to a human subject in need thereof an effective amount of repeated doses of interleukin-2 (IL-2), wherein each dose of the IL-2 is between 0.1 MIU/day and 3.5 MIU/day.
Dependencies are inferred from the claim text.